LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.80 Cr | ₹8.52 Cr | ₹6.59 Cr | ₹3.32 Cr | ₹3.16 Cr |
What is the latest Contingent Liabilities ratio of LACTOSE (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹7.80 Cr |
| Mar2024 | ₹8.52 Cr |
| Mar2023 | ₹6.59 Cr |
| Mar2022 | ₹3.32 Cr |
| Mar2021 | ₹3.16 Cr |
How is Contingent Liabilities of LACTOSE (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.80 Cr | -8.52 | |
| Mar2024 | ₹8.52 Cr | 29.32 | |
| Mar2023 | ₹6.59 Cr | 98.58 | |
| Mar2022 | ₹3.32 Cr | 4.93 | |
| Mar2021 | ₹3.16 Cr | - | |
Compare Contingent Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹122.3 Cr | -13.3% | -24.7% | -54.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -13.3% |
-24.7% |
-54.5% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses